LOS ANGELES – (March 20, 2013) – Post-menopausal women, who often suffer from joint pain, could find some long-term relief by taking estrogen-only medication, according to a new study based on the Women’s Health Initiative (WHI) that was released online today by the journal, Menopause.
LOS ANGELES – (March. 13, 2013) – Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) announced today that 33 of its physician-researchers rank among America’s Top Doctors and/or among Southern California Super Doctors. The two honors are presented annually, and they are based on recommendations from other physicians and health care professions.
LOS ANGELES – (March. 4, 2013) – Grandmother’s cigarette smoking could be responsible for her grandchild’s asthma, and the recent discovery of this multi-generational transmission of disease suggests the environmental factors experienced today could determine the health of family members for generations to come, two Los Angeles Biomedical Research Institute (LA BioMed) lead researchers write in the March edition of Review of Obstetrics and Gynecology.
LOS ANGELES (Feb. 14, 2013) – New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.
LOS ANGELES (Feb. 14, 2013) – Jerome I. Rotter, MD, a pioneer in the field of medical genetics, is joining the faculty at Los Angeles Biomedical Research Institute (LA BioMed) and bringing a team of experts to found a new institute focused on improving the health of the diverse communities served by LA BioMed and Harbor-UCLA Medical Center, David I. Meyer, PhD, LA BioMed president and CEO, announced today.
LOS ANGELES (Jan. 23, 2013) – With the rising awareness of the so-called “superbugs,” bacteria that are resistant to most known antibiotics, three infectious disease experts writing in the Jan. 24 edition of the New England Journal of Medicine called for novel approaches based on a “reconceptualization of the nature of resistance, disease and prevention.”
LOS ANGELES (Jan. 16, 2013) – In a promising finding for epileptic patients suffering from persistent seizures known as status epilepticus, researchers reported today that new medication could help halt these devastating seizures. To do so, it would have to work directly to antagonize NMDA receptors, the predominant molecular device for controlling synaptic activity and memory function in the brain.
LA BioMed was recently accredited for various research programs. Dr. Matthew Budoff is leading one such study on testosterone and its effect on the hearts of patients. (Robert Casillas / Staff Photographer)
Carlos Portillo visited LA BioMed this week, just as he has done regularly for two years, for a round of blood tests and probing questions.
Portillo, who is HIV-positive, is participating in one of the research center’s 200 ongoing clinical trials, testing a combination of medications so doctors can determine what pairings work best.
Bisphenol A, better known as BPA, was recently banned in baby bottles but the FDA stopped short of completely nixing the chemical.
A common chemical found in the lining of water bottles, aluminum cans and other food packaging may put children at risk of developing kidney and heart disease, according to a study from the NYU School of Medicine.
Researchers analyzed data on more than 700 children, focusing on the amount of Bisphenol A, better known as BPA, in their urine.
LOS ANGELES (Dec. 13, 2012) – The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), recognized as a leader in groundbreaking medical advancements and for bringing laboratory discoveries from the bench to the bedside, recently received accreditation from the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP). LA BioMed was one of five entities whose accreditation was approved at the meeting of AAHRPP’s Council on Accreditation in December.